InvestorsHub Logo
Followers 87
Posts 6646
Boards Moderated 1
Alias Born 09/18/2009

Re: None

Saturday, 07/15/2023 7:23:03 AM

Saturday, July 15, 2023 7:23:03 AM

Post# of 42779
Going back to Ajinomoto and Catalent, and then Avid, Lonza, Thermo Fisher, Cenexi, PCI Pharma, etc.,..any relationship we've had with a CDMO has left me somewhat unsettled. My manufacturing management background biased me against the modular management concept, in which we relied on Contract Development and Manufacturing Organizations (CDMO's), but, in my opinion, we didn't have any boots on the ground controlling the manufacture of our product.

So I hope that our intended partner in our business combination is PCI Pharma, and that we can conclude negotiations, and perhaps end up with an equity stake in a company that could become our product manufacturer, and more.

Whether there is any intent on using PCI Pharma in this capacity, or not, I couldn't say. But our success can't be held hostage. There are other CDMO's, and perhaps Cenexi is still a possibility. We need a Plan B, if not as a business combination candidate, then at least as a CDMO.

I fully support dedicating up to 40% of the company to a business combination into an entity that we will co-own, if that means we have ownership rights over the manufacture of our product. If the Baudax investment leads to Recro, that could also be our key to a CDMO foothold.

I think that management has amazing foresight, and I'm not used to seeing them at an impasse, which I hope they can overcome.